Imaging Cell Line

  • HT1376/RFP-firefly luciferase (CMV)  stable cells
    HT1376/RFP-firefly luciferase (CMV) stable cells
    HT1376, a human urinary bladder carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HT1376/RFP-firefly luciferase (CMV) stable cells express transgenically RFP-firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in fluorescence/bioluminescence imaging in small animal xenograft model.
    Price: $2,350.00
  • HT1376/RFP-firefly luciferase-t-HSV1-tk (CMV)  stable cells
    HT1376/RFP-firefly luciferase-t-HSV1-tk (CMV) stable cells
    HT1376, a human urinary bladder carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HT1376/RFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically RFP-firefly luciferase-HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescience and PET.
    Price: $3,350.00
  • HT-29/firefly luciferase stable cells
    HT-29/firefly luciferase stable cells
    HT-29, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HT-29/firefly luciferase stable cells express transgenically firefly luciferase under the control of the constitutive promoter.
    Price: $1,250.00
  • HT-29/firefly luciferase-VSV1-tk  stable cells
    HT-29/firefly luciferase-HSV1-tk stable cells
    HT-29, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HT-29/firefly luciferase-VSV1-tk stable cells express transgenically firefly luciferase-VSV1-tk  under the control of the constitutive promoter.
    Price: $1,250.00
  • HT-29/GFP stable cells
    HT-29/GFP stable cells
    HT-29, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HT-29/GFP stable cells express transgenically GFP under the control of the constitutive promoter.
    Price: $1,250.00
  • HT-29/GFP-firefly luciferase stable cells
    HT-29/GFP-firefly luciferase stable cells
    HT-29, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HT-29/GFP-firefly luciferase stable cells express transgenically GFP-firefly luciferase under the control of the constitutive promoter.
    Price: $2,350.00
  • HT-29/GFP-firefly luciferase-VSV1-tk  stable cells
    HT-29/GFP-firefly luciferase-HSV1-tk stable cells
    HT-29, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HT-29/GFP-firefly luciferase-VSV1-tk stable cells express transgenically GFP-firefly luciferase-VSV1-tk  under the control of the constitutive promoter.
    Price: $1,250.00
  • HT-29/VSV1-tk  stable cells
    HT-29/HSV1-tk stable cell
    HT-29, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HT-29/VSV1-tk stable cells express transgenically VSV1-tk  under the control of the constitutive promoter.
    Price: $1,250.00
  • HT-29/RFP stable cells
    HT-29/RFP stable cells
    HT-29, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HT-29/RFP stable cells express transgenically RFP under the control of the constitutive promoter.
    Price: $1,250.00
  • HT-29/RFP-firefly luciferase stable cells
    HT-29/RFP-firefly luciferase stable cells
    HT-29, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HT-29/RFP-firefly luciferase stable cells express transgenically RFP-firefly luciferase under the control of the constitutive promoter.
    Price: $3,350.00
  • HT-29/RFP-firefly luciferase-HSV1-tk stable cells
    HT-29/RFP-firefly luciferase-HSV1-tk stable cells
    HT-29, a human colorectal adenocarcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. HT-29/RFP-firefly luciferase-HSV1-tk stable cells express transgenically RFP-firefly luciferase-HSV1-tk under the control of the constitutive promoter.
    Price: $1,250.00
  • Jurkat/GFP-firefly luciferase HSV1-tk (CMV)  stable cells
    Jurkat/firefly luciferase stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Jurkat/firefly luciferase stable cells express transgenically firefly luciferase. The cell proliferation and traffing could be monitored with bioluminescience imaging in xenograft model.
    Price: $1,350.00
  • Jurkat/firefly luciferase HSV1-tk stable cells
    Jurkat/firefly luciferase-HSV1-tk stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Jurkat/firefly luciferase-HSV1-tk stable cells express transgenically firefly luciferase-HSV1-tk under the control of the constitutive promoter. The cell proliferation and trafficking could be monitored with positron emission tomography (PET) and bioluminescence imaging in xenograft model.
    Price: $2,350.00
  • Jurkat/GFP stable cells
    Jurkat/GFP stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Jurkat/GFP stable cells express transgenically GFP under the control of the constitutive promoter. The cell proliferation and traffing could be monitored with fluorescence.
    Price: $1,350.00
  • Jurkat/GFP-firefly luciferase HSV1-tk stable cells
    Jurkat/GFP-firefly luciferase stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Jurkat/GFP-firefly luciferase stable cells express transgenically GFP-firefly luciferase under the control of the constitutive promoter. The cell proliferation and trafficking could be monitored with fluorescence and bioluminescence imaging in xenograft model.
    Price: $2,350.00
  • Jurkat/GFP-firefly luciferase HSV1-tk stable cells
    Jurkat/GFP-firefly luciferase-HSV1-tk stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Jurkat/GFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically GFP-firefly luciferase-HSV1-tk under the control of the constitutive promoter. The cell proliferation and trafficking could be monitored with positron emission tomography (PET) and bioluminescence imaging in xenograft model.
    Price: $3,350.00
  • Jurkat/HSV1-tk stable cells
    Jurkat/HSV1-tk stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Jurkat/HSV1-tk stable cells express transgenically firefly luciferase. The cell proliferation and trafficking could be monitored with bioluminescience imaging in xenograft model.
    Price: $1,350.00
  • Jurkat/RFP stable cells
    Jurkat/RFP stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Jurkat/RFP stable cells express transgenically RFP under the control of the constitutive promoter. The cell proliferation and traffing could be monitored with fluorescence.
    Price: $1,350.00
  • Jurkat/RFP-firefly luciferase-t-HSV1-tk stable cells
    Jurkat/RFP-firefly luciferase-HSV1-tk stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Raw264.7/RFP-firefly luciferase-HSV1-tk stable cells express transgenically RFP-firefly luciferase-HSV1-tk under the control of the constitutive promoter. The cell proliferation and traffing could be monitored with positron emission tomography (PET) and bioluminescience imaging in xenograft model.
    Price: $3,350.00
  • Jurkat/RFP-firefly luciferase stable cells
    Jurkat/RFP-firefly luciferase-stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Raw264.7/RFP-firefly luciferase stable cells express transgenically RFP-firefly luciferase under the control of the constitutive promoter. The cell proliferation and trafficking could be monitored with fluorescence and bioluminescence imaging in xenograft model.
    Price: $2,350.00
Loading...